Alliance Growers Corp ALGWF

News..update

[Bentley2000]

ALLIANCE GROWERS GOES BEYOND CANNABIS

October 7, 2022 – Vancouver, BC – Alliance Growers Corp. (CSE: ACG; FWB:1LA; OTCPK: ALGWF) (“Alliance Growers” or “the Company) ") announces the addition of a highly qualified member to the team of Pharmagreen Biotech, Inc., (OTCQB: PHBI), (“Pharmagreen”), Alliance Growers’ Research and Technology strategic partner.
On September 22, 2022, Pharmagreen announced the addition of Ethen Styles to their team in the role of Vice President of Product Research and Development. Mr. Styles’ lifelong work with therapeutic plants, cannabis, medicinal plants and fungi, combined with years of personal studies in molecular biology, has provided Ethan with keen insight into the human health benefits provided by these plants.
Mr. Styles is a third generation Mendocino County, California legacy cannabis cultivator at Long Valley Farms. He employs veganic farming techniques to produce superior craft products and utilizes the same ultra-sustainable methods to grow a wide variety of medicinal plants and mushrooms. He developed the Company’s first nutraceutical formulation, a proprietary blend of sixteen ingredients from medicinal plants and mushrooms. Mr. Styles brings crucial knowledge and experience to Pharmagreen’s growing team, contributing his unique skillset to the Company’s vision of a diversified biotech organization expanding far beyond cannabis into a broad range of functional organic health products.
For the full article visit https://www.globenewswire.com/news-release/2022/09/22/2521164/0/en/PHBI-Pharmagreen-Biotech-Appoints-Ethan-Styles-as-Vice-President-of-Product-Research-and-Development.html
Commenting on the Addition of Mr. Styles to the Pharmagreen team, Dennis Petke, President, and CEO of Alliance Growers stated, “We are very pleased to have Pharmagreen as our strongest Strategic Partner in the Cannabis space and beyond. The addition of Mr. Styles’ experience and unique skillset strengthens the Pharmagreen team paving the way for expanded opportunities in both the US and Canada for both Alliance and Pharmagreen.  We are looking forward to expanding our relationship with the Pharmagreen team to develop products and markets beyond cannabis into a broad range of functional organic health products. We thank all our shareholders for their patience while we work to get Alliance reinstated for trading.”
Octavia Update
After receiving approval by the Liquor and Cannabis Regulation Branch for the location following months of preparation constructing the new distillery, Octavia is now able to begin production and distribution in both domestic and foreign markets. 
In the month of August 2022, Octavia received approval for retail sales in Mexico.  Octavia Mexico has initiated a digital marketing campaign targeting home and hotel delivery.
In the month of September 2022, Octavia Mexico, in addition to being granted a license allowing Octavia to market and sell their products exclusively in Mexico, the contract was expanded to include manufacturing in Mexico to offset import and duty fees to create a competitive edge. Octavia now has been approved for retail sales, manufacturing and a bottling license.
A relaunch of the Octavia brand in Canada is expected in November 2022. A new website is in progress, and we expect more updates in the coming weeks. 
About Pharmagreen Biotech, Inc.
Pharmagreen Biotech, Inc. (OTCQB: PHBI) is in the business of providing the highest quality starter plantlets utilizing a proprietary tissue culture process, "Chibafreen", to licensed cannabis cultivators and to CBD / CBG hemp farmers. It also provides other value-added services including: plant species identification through DNA testing and certification, live storage of all plant strains using tissue culture, and low temperature storage proprietary technology. The Company is utilizing the best tissue cultured plantlets in its state-of-the-art greenhouse(s) for the highest quality flower tops production. For further information on the company, please visit www.pharmagreen.ca.
About Alliance Growers Corp.
Alliance Growers is a Diversified Global Medical Cannabis Company driven by the Company’s ‘Four Pillars’ Organization Plan – 1-Products and Services for Cannabis and Hemp Cultivators through its strategic relationship with PharmaGreen Biotech Inc. (PHBI) including the supply of starter plantlets through a proprietary tissue culture process for hemp and cannabis a the supply of feminized, high percentage CBD hemp seeds; 2-Strategic Alliances with Cannabis and Hemp Cultivators, giving the Company access to indoor and outdoor grow facilities and providing hemp and cannabis products (Alliance branded pre-rolls) along with the potential for export of cannabis and hemp product; 3-CBD/THC Infused Products via “self-financed” partnerships including infused spirits and infused health related products; and 4-Research and Technology through strategic relationships with PharamaGreen, its sister company, B.R.I.M., a company with expertise in all aspects of cannabis and hemp and other entities.
The Company is in the process of updating its website and company profile with various entities. 
For further information, please visit the Company’s website at www.alliancegrowers.com or the Company’s profile at www.sedar.com.
If you would like to be added to Alliance Growers’ news and newsletter distribution list, please subscribe on the Alliance Website at www.alliancegrowers.com.
For more information contact:
Rob Grace
Communications Consultant
Tel:  [phone]
[e-mail]
 
Dennis Petke
CEO, President and Director
Tel:  [phone]
[e-mail] 
FORWARD LOOKING INFORMATION
This news release or newsletter contains forward-looking statements and forward-looking information within the meaning of applicable securities laws. These statements relate to future events or future performance. All statements other than statements of historical fact may be forward-looking statements or information. More particularly and without limitation, the news release contains forward-looking statements and information relating to Company’s corporate strategy. The forward-looking statements and information are based on certain key expectations and assumptions made by management of the Company, including, without limitation, the Company’s ability to carry out its business plan. Although management of the Company believes that the expectations and assumptions on which such forward-looking statements and information are based are reasonable, undue reliance should not be placed on the forward-looking statements and information since no assurance can be given that they will prove to be correct.
Forward-looking statements and information are provided for the purpose of providing information about the current expectations and plans of management of the Company relating to the future. Readers are cautioned that reliance on such statements and information may not be appropriate for other purposes, such as making investment decisions. Since forward-looking statements and information address future events and conditions, by their very nature they involve risks and uncertainties. Actual results could differ materially from those currently anticipated due to a number of factors and risks. These include, but are not limited to, the Company’s ability to identify and complete additional suitable acquisitions to further the Company’s growth as well as risks associated with the medical marijuana industry in general, such as operational risks in development and production delays or changes in plans with respect to development projects or capital expenditures; the uncertainty of the capital markets; the uncertainty of receiving the required licenses, production, costs and expenses; health, safety and environmental risks; marketing and transportation; loss of markets; environmental risks; competition; incorrect assessment of the value of the potential market; ability to access sufficient capital from internal and external sources; failure to obtain required regulatory and other approvals and changes in legislation, including but not limited to tax laws and regulated regulations. Accordingly, readers should not place undue reliance on the forward-looking statements, timelines and information contained in this news release. Readers are cautioned that the foregoing list of factors is not exhaustive.
The forward-looking statements and information contained in this news release are made as of the date hereof and no undertaking is given to update publicly or revise any forward-looking statements or information, whether as a result of new information, future events or otherwise, unless so required by applicable securities laws or the Canadian Securities Exchange. The forward-looking statements or information contained in this news release are expressly qualified by this cautionary statement.